Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia
Bioventus, a leader in orthobiologic solutions, announced it has selected MEDSERVICE to distribute DUROLANE® in Russia. DUROLANE is a single-injection joint-fluid based on a natural, safe and proven technology process called NASHA ® which yields stabilized hyaluronic acid (HA). Hyaluronic acid is a naturally occurring molecule that provides the lubrication and cushioning in a normal joint.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170117005896/en/
DUROLANE is a single-injection, hyaluronic acid product used for joint lubrication in the treatment of pain associated with knee osteoarthritis. (Photo: Business Wire)
In Russia, MEDSERVICE will offer DUROLANE (3ml) that is indicated for the symptomatic treatment of mild to moderate knee or hip osteoarthritis (OA) and DUROLANE SJ (1ml) associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes. MEDSERVICE, which provides a range of services to medical institutions of regional and federal levels, will distribute DUROLANE to clinicians in the Moscow metropolitan area and throughout all regions of Russia.
“We are pleased to make DUROLANE available to patients in Russia again,” said Tony Bihl, CEO, Bioventus. “This market is important to our growth in Europe and our international growth strategy overall as we strive to bring our orthobiologic solutions to patients worldwide.”
“MEDSERVICE is off to a great start with DUROLANE in Moscow and we will quickly expand to other cities and regions in Russia this year,” said Andrew McCartney, Managing Director International, for Europe, Middle East and Africa, Bioventus. “The MEDSERVICE team, and the company’s objective to help increase and develop the range of medical products and services provided to patients, is in complete alignment with Bioventus as we work together with the health care community in Russia to help people resume and enjoy active lives.”
“We are very excited to work with Bioventus to market DUROLANE in Russia,” said Alexander Yagodin, Managing Director, MEDSERVICE. “This innovative single-injection solution will safely help millions of patients better manage the pain associated with knee osteoarthritis.”
Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Its EXOGEN® Ultrasound Bone Healing System is the #1 prescribed bone healing system in the US and is the only FDA-approved bone healing device that uses safe, effective ultrasound to stimulate the body’s natural healing process. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
DUROLANE - Indications
DUROLANE (3ml) is indicated for the symptomatic treatment of mild to moderate knee or hip osteoarthritis (OA) and DUROLANE SJ (1ml) associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes.
There are no known contraindications. You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/or stiffness at the injection site. Clinical effectiveness has been demonstrated out to six months but results may vary depending on various patient factors.
Bioventus, the Bioventus logo, EXOGEN and DUROLANE are registered trademarks of Bioventus LLC. NASHA is a registered trademark of Galderma S.A.
Thomas Hill, +1-919-474-6715
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
SailPoint Closes out an Award-Winning Year in 201717.1.2018 13:00 | Pressemelding
SailPoint Technologies Holdings, Inc. (NYSE: SAIL), the leader in enterprise identity management, closed out an award-winning year in 2017, receiving industry recognition spanning technology innovation, business performance and company culture. “Last year was a phenomenal one for SailPoint on many fronts. Our goal as a company has always been to focus on delivering innovative solutions to address our customers’ identity needs, so to see that innovation highlighted by industry analysts is great validation for us,” said Mark McClain, CEO and Co-founder of SailPoint. “Likewise, our people are invaluable to us as they truly drive our company’s innovation and exemplify our core values daily, so to have them provide such positive feedback is an incredible recognition for all of us as team.” Key award wins and industry accolades achieved to close out 2017 include: SailPoint was named one of the fastest growing technology companies on Deloitte’s 2017 Technology Fast 500™ for the fifth consecut
YuppTV White Labelled OTT Platform Equips Aastha Group’s TV Channels Foray in Digital World17.1.2018 12:30 | Pressemelding
Global leader for South-Asian content, YuppTV powers Aastha Group’s TV Channels (Aastha, Aastha Bhajan, Vedic & Arihant) voyage into the world of OTT. Aastha, the pioneer spiritual and cultural brand will be utilising YuppTV’s white-labelled video platform to be present across the digital world of web, mobile, and connected TVs. Aastha mobile app was launched today by Param Pujya Swami Ramdev Ji Maharaj and Shraddhey Shree Acharya Bal Krishan Ji. On this occasion, Swami Ji stated that it's the beginning of a new era in the journey of Aastha the leading Indian Channel on spirituality and natural wellness through Yoga and Ayurveda. “Aastha” App would bring people across the world closer to Indian spirituality and meditation. Now, one can watch their favourite programs of previous nine days on “Aastha” Mobile App. anytime anywhere, as per their convenience. Extending the words of Swami Ramdev Ji, Shraddhey Balkrishan Ji said that the “Aastha” Mobile app would play a huge role in connectin
Nasdaq Will Use Rimini Street for Support of Some of Its Internal Corporate Systems17.1.2018 12:00 | Pressemelding
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced that Nasdaq will use Rimini Street for support of its human resource management system. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180117005048/en/ Nasdaq will use Rimini Street for Support of Some of its Internal Corporate Systems (Photo: Business Wire) As with all Rimini Street clients, Nasdaq has an assigned dedicated Primary Support Engineer (PSE) as its main point of contact for all support cases. Rimini Street PSE’s have an average of 15 years’ experience in their respective applications, and all clients receive industry-leading 24x7x365 service level commitments. “We are pleased to welcome Nasdaq to the fast-growing Rimini Street family of clients,” said Seth A. Ravin, Rimini Street CEO. “We have been disrupting the ent
Bank of America Reports Fourth-Quarter 2017 Financial Results17.1.2018 11:50 | Pressemelding
Bank of America reported its fourth-quarter 2017 financial results today. The news release, supplemental filing and investor presentation can be accessed in the following ways: This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180117005670/en/ Bank of America newsroom at http://newsroom.bankofamerica.com. Bank of America Investor Relations website at http://investor.bankofamerica.com. Business Wire’s news webpage at http://www.businesswire.com/portal/site/home/news. Investor Conference Call information Chief Executive Officer Brian Moynihan and Chief Financial Officer Paul Donofrio will discuss the financial results in a conference call at 8:30 a.m. ET today. For a listen-only connection to the conference call, dial 1.877.200.4456 (U.S.) or 1.785.424.1732 (international), and the conference ID is 79795. Please dial in 10 minutes prior to the start of the call. Investors can also listen to a live audio webcast of the conference c
FINEOS Momentum Continues with New Office Opening and New Jobs Driven by Product Expansion17.1.2018 10:28 | Pressemelding
FINEOS Corporation, the market leading provider of core processing systems for Life, Accident and Health insurance, today announced continued growth and momentum, including a new North American office in Atlanta, Georgia, and an increase in the workforce by 50 staff in six months. This growth has been driven by new customers in Claims, Absence and Paid Family Leave and the preference carriers have for FINEOS products in the Cloud. Speaking about the announcement, Michael Kelly, CEO, FINEOS said, “We are growing strongly, winning new business and investing heavily in FINEOS Absence and Paid Family Leave as part of FINEOS AdminSuite, our next generation core product suite for Life, Accident and Health insurance. By recruiting new talent, with the right level of business and technical expertise, we will continue to increase our market share, enter new markets and grow our overall business”. FINEOS continues to recruit for our Java Engineering practice in Dublin and Gdansk (Software Engine
1000 Girls in Pakistan to Receive Education through The Big Heart Foundation and Malala Fund17.1.2018 09:48 | Pressemelding
The Big Heart Foundation (TBHF), a global humanitarian charity based in Sharjah, UAE, is funding the second phase of a school for girls in Pakistan in keeping with its dedication to ensuring children have access to education, enabling them to contribute to the development of their communities. The project will be funded by the TBHF ‘Girl Child Fund’, in cooperation with the ‘Malala Fund’, launched by Nobel Laureate and education activist, Malala Yousafzai. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180117005590/en/ Sheikh Sultan bin Ahmed Al Qasimi and Malala Yousafzai witnessing the signing between TBHF and Malala Fund - Source: The Big Heart Foundation The initiative was announced in the presence of Sheikh Sultan bin Ahmed Al Qasimi, The Big Heart Foundation’s Humanitarian Envoy, and Malala Yousafzai following an agreement signed in Oxford by Mariam Al Hammadi, Director of TBHF, and Farah Mohamed, CEO of the Malala Fund
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom